Resveratrol prevents p53 aggregation in vitro and in breast cancer cells

One potential target for cancer therapeutics is the tumor suppressor p53, which is mutated in more than 50% of malignant tumors. Loss of function (LoF), dominant negative (DN) and gain of function (GoF) mutations in p53 are associated with amyloid aggregation. We tested the potential of resveratrol,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ferraz da Costa, Danielly C., Campos, Nathali P.C., Santos, Ronimara A., Guedes-da-Silva, Francisca Hildemagna, Martins-Dinis, Mafalda Maria D.C., Zanphorlin, Letícia, Ramos, Carlos, Rangel, Luciana P., Silva, Jerson L.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6044377/
https://ncbi.nlm.nih.gov/pubmed/30018739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25631
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados